IBIO vs PCRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 13, 2026
IBIO
PCRX
Investment Advisor Scores
PCRX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | IBIO | PCRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 9.901 | Tie |
| PEG Ratio | 0 | 0.9898 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -100.0% | -1.6% | PCRX |
| Earnings Growth | 0.0% | 483.3% | PCRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.7/100 | 50.6/100 | PCRX |
| Profit Margin | 0.0% | 5.1% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | PCRX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
IBIO
MarkdownPrice below a falling SMA50 (slope -20.3%), weak momentum, RSI 41
PCRX
MarkupPrice above SMA50, rising 50-day trend (17.6% over 20 days), RSI 83
Fundamentals Snapshot
| Metric | IBIO | PCRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -2.5 | 10.5 |
| Trailing P/E | — | 39.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | -1.0% | 0.0% |
| Gross Margin | 1.0% | 0.8% |
| Operating Margin | -301.4% | 0.0% |
| EPS | -0.27 | 0.93 |
| Dividend Yield | — | — |